Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded by William Hambrecht, WR Hambrecht + Co has been operational for over 50 years and is based in San Francisco, California. The firm specializes in providing early growth capital to companies worldwide, having supported over 500 companies to date. Their investment approach includes launching multiple venture funds, both generalist and healthcare-focused.
WR Hambrecht + Co invests in pre-seed to Series B and growth equity stages, primarily in the technology and healthcare sectors. Their strategy is informed by Disruption Theory, which targets lower-cost market segments and underserved customers. Typical check sizes are not specified, but they emphasize early disruptive companies.
Notable portfolio companies include Tasso, which developed a virtually painless blood collection device; Color Health, providing technology for large-scale health initiatives; FUV (Arcimoto), a manufacturer of affordable electric vehicles; Proov, focusing on at-home fertility diagnostics; Tango, a live streaming app; and PatientsLikeMe, a personalized health network.
Email vbryan@wrhambrecht.com with your deck to pitch WR Hambrecht + Co.
Yes, WR Hambrecht + Co often leads investment rounds, particularly in early-stage companies.
The firm is open to follow-on investments, especially if the company aligns with their focus on disruptive innovation.
Specific fund sizes are not disclosed, but the firm has launched multiple venture funds over its 50-year history.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.